PT Siloam International Hospitals Tbk Reg-S Statistics
PT Siloam International Hospitals Tbk Reg-S (SILO) Stock Statistics & Valuation Metrics
Total Valuation
PT Siloam International Hospitals Tbk Reg-S has a market cap or net worth of IDR 23.40T. The enterprise value is IDR 32.87T.
- Market Cap
- IDR 23.40T
- Enterprise Value
- IDR 32.87T
Share Statistics
PT Siloam International Hospitals Tbk Reg-S has 13,006,125,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 13,006,125,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.16%
Financial Efficiency
PT Siloam International Hospitals Tbk Reg-S’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 11.15%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- 11.15%
- Return on Capital Employed (ROCE)
- 0.17
- Revenue Per Employee
- 863.87M
- Profits Per Employee
- 74.82M
- Employee Count
- 14,872
- Asset Turnover
- 0.89
- Inventory Turnover
- 33.75
Valuation Ratios
The current PE Ratio of PT Siloam International Hospitals Tbk Reg-S is 18.62. PT Siloam International Hospitals Tbk Reg-S’s PEG ratio is 0.76.
- PE Ratio
- 18.62
- PS Ratio
- 1.71
- PB Ratio
- 2.24
- Price to FCF
- 38.92
- Price to Operating Cash Flow
- 9.54
- PEG Ratio
- 0.76
Income Statement
In the last 12 months, PT Siloam International Hospitals Tbk Reg-S had revenue of 12.85T and earned 1.11T in profits. Earnings per share was 85.68.
- Revenue
- 12.85T
- Gross Profit
- 4.95T
- Operating Income
- 1.75T
- Pretax Income
- 1.55T
- Net Income
- 1.11T
- EBITDA
- 2.89T
- Earnings Per Share (EPS)
- 85.68
Cash Flow
In the last 12 months, operating cash flow was 2.50T and capital expenditures -1.89T, giving a free cash flow of 612.46B billion.
- Operating Cash Flow
- 2.50T
- Free Cash Flow
- 612.46B
- Free Cash Flow per Share
- 47.15
Dividends & Yields
PT Siloam International Hospitals Tbk Reg-S pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.57%
- Earnings Yield
- 5.37%
Stock Price Statistics
- Beta
- 0.24
- 52-Week Price Change
- -21.74%
- 50-Day Moving Average
- 1966.30
- 200-Day Moving Average
- 2328.00
- Relative Strength Index (RSI)
- 38.11
- Average Volume (3m)
- 1.41M
Important Dates
PT Siloam International Hospitals Tbk Reg-S upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Mar 30, 2027
- Ex-Dividend Date
- ―
Financial Position
PT Siloam International Hospitals Tbk Reg-S as a current ratio of 0.79, with Debt / Equity ratio of 16.88%
- Current Ratio
- 0.79
- Quick Ratio
- 0.73
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 0.17
- Interest Coverage Ratio
- 14.27
Taxes
In the past 12 months, PT Siloam International Hospitals Tbk Reg-S has paid 380.87B in taxes.
- Income Tax
- 380.87B
- Effective Tax Rate
- 0.25
Enterprise Valuation
PT Siloam International Hospitals Tbk Reg-S EV to EBITDA ratio is 9.19, with an EV/FCF ratio of 48.65.
- EV to Sales
- 2.14
- EV to EBITDA
- 9.19
- EV to Free Cash Flow
- 48.65
- EV to Operating Cash Flow
- 11.93
Balance Sheet
PT Siloam International Hospitals Tbk Reg-S has IDR 1.64T in cash and marketable securities with IDR 7.61T in debt, giving a net cash position of -IDR 5.96T billion.
- Cash & Marketable Securities
- IDR 1.64T
- Total Debt
- IDR 7.61T
- Net Cash
- -IDR 5.96T
- Net Cash Per Share
- -IDR 458.32
- Tangible Book Value Per Share
- IDR 792.87
Margins
Gross margin is 38.23%, with operating margin of 14.02%, and net profit margin of 9.20%.
- Gross Margin
- 38.23%
- Operating Margin
- 14.02%
- Pretax Margin
- 12.69%
- Net Profit Margin
- 9.20%
- EBITDA Margin
- 23.30%
- EBIT Margin
- 13.72%
Analyst Forecast
The average price target for PT Siloam International Hospitals Tbk Reg-S is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 11.22%
- EPS Growth Forecast
- 24.44%

